NewCode Oncology Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

NewCode Oncology General Information

Description

Developer of an AI-enabled tumor classification platform designed to support precision diagnostics and drug development in oncology. The company offers ribonucleic acid-seq-based classification, scalable machine learning infrastructure, and diagnostic accuracy, enabling healthcare professionals to identify cancer types rapidly and tailor treatments for improved patient outcomes.

Contact Information

Website
www.newcode.bio
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Toronto, Ontario
  • Canada
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Corporate Office
  • Toronto, Ontario
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NewCode Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Startup
3. Accelerator/Incubator 01-May-2025 Completed Startup
2. Accelerator/Incubator 01-Mar-2025 Completed Startup
1. Spin-Off 02-Dec-2024 Completed Startup
To view NewCode Oncology’s complete valuation and funding history, request access »

NewCode Oncology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto University
The UTEST Program Accelerator/Incubator
SickKids Corporation
Ontario Genomics Accelerator/Incubator Minority
To view NewCode Oncology’s complete investors history, request access »

NewCode Oncology FAQs

  • When was NewCode Oncology founded?

    NewCode Oncology was founded in 2024.

  • Where is NewCode Oncology headquartered?

    NewCode Oncology is headquartered in Toronto, Canada.

  • What industry is NewCode Oncology in?

    NewCode Oncology’s primary industry is Decision/Risk Analysis.

  • Is NewCode Oncology a private or public company?

    NewCode Oncology is a Private company.

  • What is NewCode Oncology’s current revenue?

    The current revenue for NewCode Oncology is .

  • Who are NewCode Oncology’s investors?

    University of Toronto, The UTEST Program, SickKids, and Ontario Genomics have invested in NewCode Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process